Benjamin J. Hickey
Overview
Benjamin J. Hickey received an average of $3M in total compensation, including $314K in salary, at Halozyme Therapeutics between 2018 and 2019.
Source: SEC filings on March 20, 2020 and March 22, 2019.
Related executives
We found 21 more executives who work or worked at Halozyme Therapeutics.
Helen Torley
Halozyme Therapeutics
Chief Executive Officer
Masaru Matsuda
Halozyme Therapeutics
General Counsel
Michael LaBarre
Halozyme Therapeutics
Senior Vice President, Chief Technical Officer
Elaine Sun
Halozyme Therapeutics
Chief Financial Officer
Laurie Stelzer
Halozyme Therapeutics
Chief Financial Officer
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
Harry Leonhardt
Halozyme Therapeutics
General Counsel
Dimitrios Chondros
Halozyme Therapeutics